Eliza has more than 25 years of experience in therapeutic drug development, spanning early discovery through late-stage development, across pharmaceutical, contract research, and CDMO organizations, including Novazyme, Genzyme, Analytical Research Laboratory, and, most recently, Cytovance Biologics.